# Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

> **NCT00067470** · PHASE3 · COMPLETED · sponsor: **BioMarin Pharmaceutical** · enrollment: 39 (actual)

## Conditions studied

- Mucopolysaccharidosis VI

## Interventions

- **DRUG:** Placebo
- **DRUG:** N-acetylgalactosamine 4-sulfatase

## Key facts

- **NCT ID:** NCT00067470
- **Lead sponsor:** BioMarin Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067470, "Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00067470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*